Metraipolis › archive › dc_72bba1e44510
The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma — Europe PMC PMID:42500564
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42500564
- DOI
- 10.32604/or.2026.080413
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T08:04:57.773Z
- SHA-256 of the archived text
1390ab62272d62d192a7d517ae1182759a3e92c9cb0177b34d82c3ce5514440b- Stable URL of this page
https://metraipolis.com/documento/dc_72bba1e44510
How to cite
The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma — Europe PMC PMID:42500564 — Europe PMC (en), https://europepmc.org/article/MED/42500564 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72bba1e44510 (Metraipolis archive dc_72bba1e44510, sha256 1390ab62272d62d192a7d517ae1182759a3e92c9cb0177b34d82c3ce5514440b)
BibTeX
@misc{dc72bba1e44510,
title = {The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma — Europe PMC PMID:42500564},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42500564},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72bba1e44510; sha256 1390ab62272d62d192a7d517ae1182759a3e92c9cb0177b34d82c3ce5514440b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42500564. Agents can read the archived copy with the MCP tool read_document.